An opinion piece written by Ronald Trowbridge and Steven Walker appeared today in the WSJ. The piece is centered on the recent decision of the full D.C. Circuit Court of Appeals that reversed its own smaller panel’s 2 to 1 decision to allow dying, terminal patient’s access to investigational drugs that have been found to [...]
Today, I want to following up on yesterday’s bad news about the Court of Appeals decision that will prevent terminal cancer patients from having access to safe drugs. We all need to respond immediately to out members in congress. We want to let them know that we need legislation now that directs the FDA to [...]
Late this afternoon U.S. Court of Appeals for the District of Columbia ruled that terminally ill patients do NOT have the constitutional right to obtain experimental drugs that have not been approved by the FDA! The Abigal Alliance for Better Access to Developmental Drugs and the Washington Legal Foundation argued that terminally ill patients, including [...]
I thought that I would share the testimony I delivered at the recent FDA hearing on Satraplatin: My name is Joel T. Nowak. I am here today as a consumer and as a representative of the advocacy and educational group Malecare. Neither I, nor any member of my family have any financial interest nor received [...]
Lately, I have been writing about the significant disappointment and anger I feel towards the FDA. Congress has directed the FDA and the FDA’s own regulations require that they have a system for accelerated approval of drugs. Yes, they do have the regulations in place, but they have stopped abiding by their own rules. The [...]